Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
This webinar was broadcasted after the publication of the new version of the Valvular Heart Diseases (VHDs) Guidelines in August.
Three clinical cases were discussed:
The first case was a 40-year-old pregnant female with Bicuspid Valve AS. Apparently the AS got worse; but in the presence of a condition of reversible high flow, which may elevate the valvular gradient, it is necessary to re-evaluate the AS after delivery. In severe AS, intervention should be guaranteed in presence of a low EF, symptoms or symptom development during an exercise test, and also marked BNP elevation and pulmonary hypertension development. In patients at low risk, the SAVR is still the choice.
The second case highlighted the essential role of the heart team in the management. The patient studied was very old, and presented a very high risk due to CAD, peripheral VD, PM for II BAV, COPD. The intervention choice was a trans-apical approach TAVI (he was not suitable for SAVR and not for trans-femoral TAVI approach). This case was very useful to discuss the issues in favour of the indication for TAVI vs SAVR.
The third case was a very complex patient with a previous replacement of the aortic root and ascending aorta with severe Aortic Regurgitation, very low EF (20%), severe MR. In this very difficult and risky situation, an operation using a SAVR, and a mitral valve repair may be the solution.
Please find here enclosed the replies from the Faculty members to the questions left unanswered during the live event.
Professor Bernard Iung, FESCDepartment of CardiologyBichat Hospital, Paris, France
Professor Olaf Wendler Consultant Cardiothoracic SurgeonKings' College Hospital, London, United Kingdom
Doctor Dimitri Richter, FESCHead of Cardiac Department Euroclinic Hospital, Athens, Greece
This webinar addresses General Cardiologists, Cardiologists in training, Internal Medicine specialists, Geriatricians & General Practitioners.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
An application has been made to the EACCME® for CME accreditation of this event.
The webinar is available on PC and Tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Edwards Lifesciences in the form of an educational grant.
The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved